These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification and Immune Assessment of T Cell Epitopes in Five Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR Front Immunol; 2021; 12():690348. PubMed ID: 34305923 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
6. Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine. Bermúdez A; Vanegas M; Patarroyo ME Vaccine; 2008 Dec; 26(52):6908-18. PubMed ID: 18930095 [TBL] [Abstract][Full Text] [Related]
7. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion. Patarroyo ME; Bermúdez A; Salazar LM; Espejo F Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708 [TBL] [Abstract][Full Text] [Related]
8. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria. Cifuentes G; Espejo F; Vargas LE; Parra C; Vanegas M; Patarroyo ME Biochemistry; 2004 Jun; 43(21):6545-53. PubMed ID: 15157087 [TBL] [Abstract][Full Text] [Related]
9. Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine. Patarroyo ME; Cifuentes G; Rodríguez R Int J Biochem Cell Biol; 2008; 40(3):543-57. PubMed ID: 17997122 [TBL] [Abstract][Full Text] [Related]
10. Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria. Bermúdez A; Alba P; Espejo F; Vargas LE; Parra C; Rodríguez R; Reyes C; Patarroyo ME Int J Biochem Cell Biol; 2005 Feb; 37(2):336-49. PubMed ID: 15474979 [TBL] [Abstract][Full Text] [Related]
11. 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening. Alba MP; Salazar LM; Puentes A; Pinto M; Torres E; Patarroyo ME Peptides; 2003 Jul; 24(7):999-1006. PubMed ID: 14499278 [TBL] [Abstract][Full Text] [Related]
12. Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective. Cifuentes G; Patarroyo ME; Urquiza M; Ramirez LE; Reyes C; Rodriguez R J Med Chem; 2003 May; 46(11):2250-3. PubMed ID: 12747797 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure. Bermúdez A; Moreno-Vranich A; Patarroyo ME Amino Acids; 2012 Jul; 43(1):183-94. PubMed ID: 21894529 [TBL] [Abstract][Full Text] [Related]
14. Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine. Curtidor H; Vanegas M; Alba MP; Patarroyo ME Curr Med Chem; 2011; 18(29):4470-502. PubMed ID: 22029724 [TBL] [Abstract][Full Text] [Related]
15. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides. Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the development of a chemically synthesised anti-malarial vaccine. Curtidor H; Patarroyo ME; Patarroyo MA Expert Opin Biol Ther; 2015; 15(11):1567-81. PubMed ID: 26239009 [TBL] [Abstract][Full Text] [Related]
17. A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development. Cifuentes G; Patarroyo ME; Reyes C; Córtes J; Patarroyo MA Biochem Biophys Res Commun; 2007 Aug; 360(1):149-55. PubMed ID: 17588541 [TBL] [Abstract][Full Text] [Related]
18. Protection against experimental P falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures. Cubillos M; Salazar LM; Torres L; Patarroyo ME Biochimie; 2002 Dec; 84(12):1181-8. PubMed ID: 12628294 [TBL] [Abstract][Full Text] [Related]
19. Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys. Curtidor H; Torres MH; Alba MP; Patarroyo ME Biol Chem; 2007 Jan; 388(1):25-36. PubMed ID: 17214546 [TBL] [Abstract][Full Text] [Related]
20. Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria. Espejo F; Bermúdez A; Torres E; Urquiza M; Rodríguez R; López Y; Patarroyo ME Biochem Biophys Res Commun; 2004 Mar; 315(2):418-27. PubMed ID: 14766224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]